• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调查外科医生对非小细胞肺癌术中淋巴结评估范围的实践情况和观点。

Surveying surgeon practices and perspectives on extent of intraoperative nodal evaluation in non-small cell lung cancer.

作者信息

Walsh Lyndon C, Brunelli Alessandro, Kidane Biniam, Eckhaus Jazmin, Fiset Pierre Olivier, Spicer Jonathan D, Antonoff Mara B

机构信息

Department of Cardiovascular and Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex.

Department of Thoracic Surgery, Montréal General Hospital, Montréal, Québec, Canada.

出版信息

JTCVS Open. 2025 Jan 31;24:376-382. doi: 10.1016/j.xjon.2025.01.010. eCollection 2025 Apr.

DOI:10.1016/j.xjon.2025.01.010
PMID:40309672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12039416/
Abstract

OBJECTIVE

The National Comprehensive Cancer Network and Commission on Cancer guidelines encourage surgeons to obtain tissue from 1 or more N1 and 3 N2 nodal stations during resection for non-small cell lung cancer. We aimed to characterize surgeons' familiarity with and adherence to recommended guidelines and to elucidate factors influencing surgical practices globally.

METHODS

A questionnaire was designed to assess surgeon behaviors regarding intraoperative nodal assessment decisions during lung cancer resection. Survey items included demographics, case-based scenarios, self-perceived behaviors regarding nodal decision-making, and knowledge-based questions regarding nodal assessment guidelines. The survey was distributed to the General Thoracic Surgical Club, European Society of Thoracic Surgeons, Canadian Association of Thoracic Surgeons, and Australian & New Zealand Society of Cardiac & Thoracic Surgeons.

RESULTS

Altogether, 236 of 2396 surgeons (9.8%) from 46 countries responded. The majority were men (192/236) and general thoracic surgeons (204/236). Participants were subcategorized into North America (n = 96), Europe (n = 96), and All Other (n = 44). The importance of 4 variables that impact lymph node excision varied by region: length of procedure ( = .04), patient age ( = .0004), patient frailty ( = .0034), and institutional guidelines ( = .01). Surgeons stated that in patients who received neoadjuvant treatment, most would opt for a full lymphadenectomy. A total of 80.5% (n = 190) claimed familiarity with guidelines, yet only 56.4% (n = 133) could identify the guidelines.

CONCLUSIONS

The variables driving intraoperative decision-making for nodal dissection vary by region. Moreover, surgeons tend to overstate their knowledge of existing guidelines. To optimize cancer care around the world, education needs to be provided uniformly to drive positive patient outcomes.

摘要

目的

美国国立综合癌症网络和癌症委员会指南鼓励外科医生在非小细胞肺癌切除术中从1个或更多N1和3个N2淋巴结站获取组织。我们旨在描述外科医生对推荐指南的熟悉程度和遵循情况,并阐明全球影响手术操作的因素。

方法

设计了一份问卷,以评估外科医生在肺癌切除术中关于术中淋巴结评估决策的行为。调查项目包括人口统计学、基于病例的情景、关于淋巴结决策的自我认知行为以及关于淋巴结评估指南的基于知识的问题。该调查分发给了普通胸外科俱乐部、欧洲胸外科医师协会、加拿大胸外科医师协会以及澳大利亚和新西兰心胸外科医师协会。

结果

来自46个国家的2396名外科医生中共有236名(9.8%)做出了回应。大多数是男性(192/236)和普通胸外科医生(204/236)。参与者被细分为北美(n = 96)、欧洲(n = 96)和所有其他地区(n = 44)。影响淋巴结切除的4个变量的重要性因地区而异:手术时长(P = 0.04)、患者年龄(P = 0.0004)、患者虚弱程度(P = 0.0034)和机构指南(P = 0.01)。外科医生表示,在接受新辅助治疗的患者中,大多数会选择进行完整的淋巴结清扫术。共有80.5%(n = 190)的人声称熟悉指南,但只有56.4%(n = 133)能够识别这些指南。

结论

驱动术中淋巴结清扫决策的变量因地区而异。此外,外科医生往往夸大他们对现有指南的了解。为了在全球范围内优化癌症治疗,需要统一提供教育以推动积极的患者治疗结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8e/12039416/357e3a90f9ea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8e/12039416/7acffbe63261/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8e/12039416/357e3a90f9ea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8e/12039416/7acffbe63261/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8e/12039416/357e3a90f9ea/gr1.jpg

相似文献

1
Surveying surgeon practices and perspectives on extent of intraoperative nodal evaluation in non-small cell lung cancer.调查外科医生对非小细胞肺癌术中淋巴结评估范围的实践情况和观点。
JTCVS Open. 2025 Jan 31;24:376-382. doi: 10.1016/j.xjon.2025.01.010. eCollection 2025 Apr.
2
Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation.系统性淋巴结清扫术中观察者间的变异性:欧洲和日本淋巴结命名法的比较
Ann Thorac Surg. 2002 Jan;73(1):245-8; discussion 248-9. doi: 10.1016/s0003-4975(01)03177-0.
3
A National Survey of Surgeons Evaluating the Accuracy of Mediastinal Lymph Node Identification.一项评估纵隔淋巴结识别准确性的外科医生全国性调查。
Clin Lung Cancer. 2023 Jul;24(5):445-452. doi: 10.1016/j.cllc.2023.03.005. Epub 2023 Mar 21.
4
Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).支气管内与食管内超声联合用于肺癌诊断及分期:欧洲胃肠内镜学会(ESGE)指南,与欧洲呼吸学会(ERS)及欧洲胸外科医师学会(ESTS)合作制定
Endoscopy. 2015 Jun;47(6):545-59. doi: 10.1055/s-0034-1392040. Epub 2015 Jun 1.
5
Is sampling really effective in staging non-small cell lung cancer? A prospective study.采样在非小细胞肺癌分期中真的有效吗?一项前瞻性研究。
Chir Ital. 2006 Jan-Feb;58(1):19-22.
6
Pretreatment Invasive Nodal Staging in Lung Cancer: Knowledge, Attitudes, and Beliefs Among Academic and Community Physicians.肺癌术前侵袭性淋巴结分期:学术和社区医生的知识、态度和信念。
Chest. 2022 Mar;161(3):826-832. doi: 10.1016/j.chest.2021.11.010. Epub 2021 Nov 18.
7
Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC.对癌症委员会关于早期非小细胞肺癌术中淋巴结采样的更新指南的评估
J Thorac Oncol. 2022 Nov;17(11):1287-1296. doi: 10.1016/j.jtho.2022.08.009. Epub 2022 Aug 30.
8
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.非小细胞肺癌术中淋巴结分期的欧洲胸外科医师协会指南
Eur J Cardiothorac Surg. 2006 Nov;30(5):787-92. doi: 10.1016/j.ejcts.2006.08.008. Epub 2006 Sep 12.
9
Dual intervention to improve pathologic staging of resectable lung cancer.双重干预以改善可切除肺癌的病理分期。
Ann Thorac Surg. 2013 Dec;96(6):1975-81. doi: 10.1016/j.athoracsur.2013.07.009. Epub 2013 Sep 23.
10
Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.北美胸外科医生治疗 IIIA 期非小细胞肺癌。
Ann Thorac Surg. 2012 Sep;94(3):922-6; discussion 926-8. doi: 10.1016/j.athoracsur.2012.04.087. Epub 2012 Jun 27.

本文引用的文献

1
Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study.淋巴结清扫范围对切除术后复发的非小细胞肺癌免疫治疗疗效的影响:一项多机构回顾性队列研究
Int J Surg. 2024 Jan 1;110(1):238-252. doi: 10.1097/JS9.0000000000000774.
2
The barriers and facilitators for the implementation of clinical practice guidelines in healthcare: an umbrella review of qualitative and quantitative literature.临床实践指南在医疗保健中的实施障碍和促进因素:定性和定量文献的伞式综述。
J Clin Epidemiol. 2023 Oct;162:169-181. doi: 10.1016/j.jclinepi.2023.08.017. Epub 2023 Aug 30.
3
Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC.
对癌症委员会关于早期非小细胞肺癌术中淋巴结采样的更新指南的评估
J Thorac Oncol. 2022 Nov;17(11):1287-1296. doi: 10.1016/j.jtho.2022.08.009. Epub 2022 Aug 30.
4
What Promotes Surgeon Practice Change? A Scoping Review of Innovation Adoption in Surgical Practice.什么促进了外科医生的实践改变?手术实践中创新采用的范围综述。
Ann Surg. 2021 Mar 1;273(3):474-482. doi: 10.1097/SLA.0000000000004355.
5
Mediastinal lymphadenectomy fulfilling NCCN criteria may improve the outcome of clinical N0-1 and pathological N2 non-small cell lung cancer.符合美国国立综合癌症网络(NCCN)标准的纵隔淋巴结清扫术可能改善临床N0-1期及病理N2期非小细胞肺癌的治疗效果。
J Thorac Dis. 2016 Mar;8(3):342-9. doi: 10.21037/jtd.2016.02.49.
6
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.非小细胞肺癌术前纵隔淋巴结分期的修订版欧洲胸外科医师协会指南。
Eur J Cardiothorac Surg. 2014 May;45(5):787-98. doi: 10.1093/ejcts/ezu028. Epub 2014 Feb 26.
7
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.随机对照试验:在 N0 或 N1(肺门淋巴结转移阴性)非小细胞肺癌患者的肺切除术中,纵隔淋巴结采样与完全淋巴结清扫的比较:美国外科医师学院肿瘤学组 Z0030 试验结果。
J Thorac Cardiovasc Surg. 2011 Mar;141(3):662-70. doi: 10.1016/j.jtcvs.2010.11.008.
8
The dillman total design survey method.迪尔曼总设计调查法。
Can Fam Physician. 1986 Nov;32:2366-8.
9
The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.国际肺癌研究协会肺癌分期项目:关于在即将出版的第七版肺癌TNM分类中制定新的国际淋巴结图谱的提议。
J Thorac Oncol. 2009 May;4(5):568-77. doi: 10.1097/JTO.0b013e3181a0d82e.
10
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.非小细胞肺癌术中淋巴结分期的欧洲胸外科医师协会指南
Eur J Cardiothorac Surg. 2006 Nov;30(5):787-92. doi: 10.1016/j.ejcts.2006.08.008. Epub 2006 Sep 12.